Trastuzumab for HER2-Positive Metastatic Breast Cancer: Clinical and Economic Considerations

Trastuzumab for HER2-Positive Metastatic Breast Cancer: Clinical and Economic Considerations

Show other versions (1)
Bibliographic Details
Main Authors: Alwin Jeyakumar, Tallal Younis
Format: Article
Language:English
Published: SAGE Publishing 2012-04-01
Series:Clinical Medicine Insights: Oncology
Online Access:http://la-press.com/trastuzumab-for-her2-positive-metastatic-breast-cancer-clinical-and-ec-a3123
id doaj-722f9c7ef4bf405ca572a675c02ebf8e
record_format Article
spelling doaj-722f9c7ef4bf405ca572a675c02ebf8e2020-11-25T03:43:56ZengSAGE PublishingClinical Medicine Insights: Oncology1179-55492012-04-0120126179187Trastuzumab for HER2-Positive Metastatic Breast Cancer: Clinical and Economic ConsiderationsAlwin JeyakumarTallal Younishttp://la-press.com/trastuzumab-for-her2-positive-metastatic-breast-cancer-clinical-and-ec-a3123
collection DOAJ
language English
format Article
sources DOAJ
author Alwin Jeyakumar
Tallal Younis
spellingShingle Alwin Jeyakumar
Tallal Younis
Trastuzumab for HER2-Positive Metastatic Breast Cancer: Clinical and Economic Considerations
Clinical Medicine Insights: Oncology
author_facet Alwin Jeyakumar
Tallal Younis
author_sort Alwin Jeyakumar
title Trastuzumab for HER2-Positive Metastatic Breast Cancer: Clinical and Economic Considerations
title_short Trastuzumab for HER2-Positive Metastatic Breast Cancer: Clinical and Economic Considerations
title_full Trastuzumab for HER2-Positive Metastatic Breast Cancer: Clinical and Economic Considerations
title_fullStr Trastuzumab for HER2-Positive Metastatic Breast Cancer: Clinical and Economic Considerations
title_full_unstemmed Trastuzumab for HER2-Positive Metastatic Breast Cancer: Clinical and Economic Considerations
title_sort trastuzumab for her2-positive metastatic breast cancer: clinical and economic considerations
publisher SAGE Publishing
series Clinical Medicine Insights: Oncology
issn 1179-5549
publishDate 2012-04-01
url http://la-press.com/trastuzumab-for-her2-positive-metastatic-breast-cancer-clinical-and-ec-a3123
work_keys_str_mv AT alwinjeyakumar trastuzumabforher2positivemetastaticbreastcancerclinicalandeconomicconsiderations
AT tallalyounis trastuzumabforher2positivemetastaticbreastcancerclinicalandeconomicconsiderations
_version_ 1724517304032559104

Similar Items